Global Targeted Protein Degradation Therapy Market Growth (Status and Outlook) 2026-2032標的タンパク質分解療法の世界市場 2026-2032年 The global Targeted Protein Degradation Therapy market size is predicted to grow from US$ 130 million in 2025 to US$ 428 million in 2032; it is expected to grow at a CAGR of 18.9% from 2026 to 2032... もっと見る
英語原文をAIを使って翻訳しています。
図表リストList of TablesTable 1. Targeted Protein Degradation Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions) Table 2. Targeted Protein Degradation Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions) Table 3. Major Players of Molecular Glues (CELMoDTM Agents) Table 4. Major Players of Ligand-directed Degraders (LDDs) Table 5. Major Players of Antibody Drug Conjugate (ADC) Degraders Table 6. Targeted Protein Degradation Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions) Table 7. Global Targeted Protein Degradation Therapy Market Size by Type (2021-2026) & ($ millions) Table 8. Global Targeted Protein Degradation Therapy Market Size Market Share by Type (2021-2026) Table 9. Targeted Protein Degradation Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions) Table 10. Global Targeted Protein Degradation Therapy Market Size by Application (2021-2026) & ($ millions) Table 11. Global Targeted Protein Degradation Therapy Market Size Market Share by Application (2021-2026) Table 12. Global Targeted Protein Degradation Therapy Revenue by Player (2021-2026) & ($ millions) Table 13. Global Targeted Protein Degradation Therapy Revenue Market Share by Player (2021-2026) Table 14. Targeted Protein Degradation Therapy Key Players Head office and Products Offered Table 15. Targeted Protein Degradation Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) Table 16. New Products and Potential Entrants Table 17. Mergers & Acquisitions, Expansion Table 18. Global Targeted Protein Degradation Therapy Market Size by Region (2021-2026) & ($ millions) Table 19. Global Targeted Protein Degradation Therapy Market Size Market Share by Region (2021-2026) Table 20. Global Targeted Protein Degradation Therapy Revenue by Country/Region (2021-2026) & ($ millions) Table 21. Global Targeted Protein Degradation Therapy Revenue Market Share by Country/Region (2021-2026) Table 22. Americas Targeted Protein Degradation Therapy Market Size by Country (2021-2026) & ($ millions) Table 23. Americas Targeted Protein Degradation Therapy Market Size Market Share by Country (2021-2026) Table 24. Americas Targeted Protein Degradation Therapy Market Size by Type (2021-2026) & ($ millions) Table 25. Americas Targeted Protein Degradation Therapy Market Size Market Share by Type (2021-2026) Table 26. Americas Targeted Protein Degradation Therapy Market Size by Application (2021-2026) & ($ millions) Table 27. Americas Targeted Protein Degradation Therapy Market Size Market Share by Application (2021-2026) Table 28. APAC Targeted Protein Degradation Therapy Market Size by Region (2021-2026) & ($ millions) Table 29. APAC Targeted Protein Degradation Therapy Market Size Market Share by Region (2021-2026) Table 30. APAC Targeted Protein Degradation Therapy Market Size by Type (2021-2026) & ($ millions) Table 31. APAC Targeted Protein Degradation Therapy Market Size by Application (2021-2026) & ($ millions) Table 32. Europe Targeted Protein Degradation Therapy Market Size by Country (2021-2026) & ($ millions) Table 33. Europe Targeted Protein Degradation Therapy Market Size Market Share by Country (2021-2026) Table 34. Europe Targeted Protein Degradation Therapy Market Size by Type (2021-2026) & ($ millions) Table 35. Europe Targeted Protein Degradation Therapy Market Size by Application (2021-2026) & ($ millions) Table 36. Middle East & Africa Targeted Protein Degradation Therapy Market Size by Region (2021-2026) & ($ millions) Table 37. Middle East & Africa Targeted Protein Degradation Therapy Market Size by Type (2021-2026) & ($ millions) Table 38. Middle East & Africa Targeted Protein Degradation Therapy Market Size by Application (2021-2026) & ($ millions) Table 39. Key Market Drivers & Growth Opportunities of Targeted Protein Degradation Therapy Table 40. Key Market Challenges & Risks of Targeted Protein Degradation Therapy Table 41. Key Industry Trends of Targeted Protein Degradation Therapy Table 42. Global Targeted Protein Degradation Therapy Market Size Forecast by Region (2027-2032) & ($ millions) Table 43. Global Targeted Protein Degradation Therapy Market Size Market Share Forecast by Region (2027-2032) Table 44. Global Targeted Protein Degradation Therapy Market Size Forecast by Type (2027-2032) & ($ millions) Table 45. Global Targeted Protein Degradation Therapy Market Size Forecast by Application (2027-2032) & ($ millions) Table 46. Arvinas Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 47. Arvinas Targeted Protein Degradation Therapy Product Offered Table 48. Arvinas Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 49. Arvinas Main Business Table 50. Arvinas Latest Developments Table 51. Kymera Therapeutics Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 52. Kymera Therapeutics Targeted Protein Degradation Therapy Product Offered Table 53. Kymera Therapeutics Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 54. Kymera Therapeutics Main Business Table 55. Kymera Therapeutics Latest Developments Table 56. Dialectic Therapeutics Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 57. Dialectic Therapeutics Targeted Protein Degradation Therapy Product Offered Table 58. Dialectic Therapeutics Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 59. Dialectic Therapeutics Main Business Table 60. Dialectic Therapeutics Latest Developments Table 61. Bristol-Myers Squibb Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 62. Bristol-Myers Squibb Targeted Protein Degradation Therapy Product Offered Table 63. Bristol-Myers Squibb Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 64. Bristol-Myers Squibb Main Business Table 65. Bristol-Myers Squibb Latest Developments Table 66. Nurix Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 67. Nurix Targeted Protein Degradation Therapy Product Offered Table 68. Nurix Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 69. Nurix Main Business Table 70. Nurix Latest Developments Table 71. Cullgen Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 72. Cullgen Targeted Protein Degradation Therapy Product Offered Table 73. Cullgen Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 74. Cullgen Main Business Table 75. Cullgen Latest Developments Table 76. C4 Therapeutics Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 77. C4 Therapeutics Targeted Protein Degradation Therapy Product Offered Table 78. C4 Therapeutics Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 79. C4 Therapeutics Main Business Table 80. C4 Therapeutics Latest Developments Table 81. Foghorn Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 82. Foghorn Targeted Protein Degradation Therapy Product Offered Table 83. Foghorn Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 84. Foghorn Main Business Table 85. Foghorn Latest Developments Table 86. Novartis Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 87. Novartis Targeted Protein Degradation Therapy Product Offered Table 88. Novartis Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 89. Novartis Main Business Table 90. Novartis Latest Developments Table 91. Pfizer Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 92. Pfizer Targeted Protein Degradation Therapy Product Offered Table 93. Pfizer Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 94. Pfizer Main Business Table 95. Pfizer Latest Developments Table 96. MSD Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 97. MSD Targeted Protein Degradation Therapy Product Offered Table 98. MSD Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 99. MSD Main Business Table 100. MSD Latest Developments Table 101. Origami Therapeutics Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 102. Origami Therapeutics Targeted Protein Degradation Therapy Product Offered Table 103. Origami Therapeutics Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 104. Origami Therapeutics Main Business Table 105. Origami Therapeutics Latest Developments Table 106. NEOsphere Biotechnologies Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 107. NEOsphere Biotechnologies Targeted Protein Degradation Therapy Product Offered Table 108. NEOsphere Biotechnologies Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 109. NEOsphere Biotechnologies Main Business Table 110. NEOsphere Biotechnologies Latest Developments Table 111. Dunad Therapeutics Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 112. Dunad Therapeutics Targeted Protein Degradation Therapy Product Offered Table 113. Dunad Therapeutics Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 114. Dunad Therapeutics Main Business Table 115. Dunad Therapeutics Latest Developments Table 116. Entact Bio Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 117. Entact Bio Targeted Protein Degradation Therapy Product Offered Table 118. Entact Bio Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 119. Entact Bio Main Business Table 120. Entact Bio Latest Developments Table 121. Proxygen Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 122. Proxygen Targeted Protein Degradation Therapy Product Offered Table 123. Proxygen Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 124. Proxygen Main Business Table 125. Proxygen Latest Developments Table 126. Monte Rosa Therapeutics Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 127. Monte Rosa Therapeutics Targeted Protein Degradation Therapy Product Offered Table 128. Monte Rosa Therapeutics Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 129. Monte Rosa Therapeutics Main Business Table 130. Monte Rosa Therapeutics Latest Developments Table 131. Treeline Biosciences Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 132. Treeline Biosciences Targeted Protein Degradation Therapy Product Offered Table 133. Treeline Biosciences Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 134. Treeline Biosciences Main Business Table 135. Treeline Biosciences Latest Developments Table 136. Ubiquigent Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 137. Ubiquigent Targeted Protein Degradation Therapy Product Offered Table 138. Ubiquigent Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 139. Ubiquigent Main Business Table 140. Ubiquigent Latest Developments Table 141. Kangpu Biopharmaceuticals Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 142. Kangpu Biopharmaceuticals Targeted Protein Degradation Therapy Product Offered Table 143. Kangpu Biopharmaceuticals Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 144. Kangpu Biopharmaceuticals Main Business Table 145. Kangpu Biopharmaceuticals Latest Developments Table 146. Ranok Therapeutics Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 147. Ranok Therapeutics Targeted Protein Degradation Therapy Product Offered Table 148. Ranok Therapeutics Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 149. Ranok Therapeutics Main Business Table 150. Ranok Therapeutics Latest Developments Table 151. Accutar Biotech Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 152. Accutar Biotech Targeted Protein Degradation Therapy Product Offered Table 153. Accutar Biotech Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 154. Accutar Biotech Main Business Table 155. Accutar Biotech Latest Developments Table 156. BeiGene Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 157. BeiGene Targeted Protein Degradation Therapy Product Offered Table 158. BeiGene Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 159. BeiGene Main Business Table 160. BeiGene Latest Developments Table 161. Hinova Pharma Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 162. Hinova Pharma Targeted Protein Degradation Therapy Product Offered Table 163. Hinova Pharma Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 164. Hinova Pharma Main Business Table 165. Hinova Pharma Latest Developments Table 166. Haisco Pharmaceutical Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 167. Haisco Pharmaceutical Targeted Protein Degradation Therapy Product Offered Table 168. Haisco Pharmaceutical Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 169. Haisco Pharmaceutical Main Business Table 170. Haisco Pharmaceutical Latest Developments Table 171. CTTQ Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 172. CTTQ Targeted Protein Degradation Therapy Product Offered Table 173. CTTQ Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 174. CTTQ Main Business Table 175. CTTQ Latest Developments List of Figures Figure 1. Targeted Protein Degradation Therapy Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Targeted Protein Degradation Therapy Market Size Growth Rate (2021-2032) ($ millions) Figure 6. Targeted Protein Degradation Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions) Figure 7. Targeted Protein Degradation Therapy Sales Market Share by Country/Region (2025) Figure 8. Targeted Protein Degradation Therapy Sales Market Share by Country/Region (2021, 2025 & 2032) Figure 9. Global Targeted Protein Degradation Therapy Market Size Market Share by Type in 2025 Figure 10. Targeted Protein Degradation Therapy in Prostate Cancer Figure 11. Global Targeted Protein Degradation Therapy Market: Prostate Cancer (2021-2026) & ($ millions) Figure 12. Targeted Protein Degradation Therapy in Breast Cancer Figure 13. Global Targeted Protein Degradation Therapy Market: Breast Cancer (2021-2026) & ($ millions) Figure 14. Targeted Protein Degradation Therapy in Lymphoma Figure 15. Global Targeted Protein Degradation Therapy Market: Lymphoma (2021-2026) & ($ millions) Figure 16. Targeted Protein Degradation Therapy in Others Figure 17. Global Targeted Protein Degradation Therapy Market: Others (2021-2026) & ($ millions) Figure 18. Global Targeted Protein Degradation Therapy Market Size Market Share by Application in 2025 Figure 19. Global Targeted Protein Degradation Therapy Revenue Market Share by Player in 2025 Figure 20. Global Targeted Protein Degradation Therapy Market Size Market Share by Region (2021-2026) Figure 21. Americas Targeted Protein Degradation Therapy Market Size 2021-2026 ($ millions) Figure 22. APAC Targeted Protein Degradation Therapy Market Size 2021-2026 ($ millions) Figure 23. Europe Targeted Protein Degradation Therapy Market Size 2021-2026 ($ millions) Figure 24. Middle East & Africa Targeted Protein Degradation Therapy Market Size 2021-2026 ($ millions) Figure 25. Americas Targeted Protein Degradation Therapy Value Market Share by Country in 2025 Figure 26. United States Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 27. Canada Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 28. Mexico Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 29. Brazil Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 30. APAC Targeted Protein Degradation Therapy Market Size Market Share by Region in 2025 Figure 31. APAC Targeted Protein Degradation Therapy Market Size Market Share by Type (2021-2026) Figure 32. APAC Targeted Protein Degradation Therapy Market Size Market Share by Application (2021-2026) Figure 33. China Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 34. Japan Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 35. South Korea Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 36. Southeast Asia Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 37. India Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 38. Australia Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 39. Europe Targeted Protein Degradation Therapy Market Size Market Share by Country in 2025 Figure 40. Europe Targeted Protein Degradation Therapy Market Size Market Share by Type (2021-2026) Figure 41. Europe Targeted Protein Degradation Therapy Market Size Market Share by Application (2021-2026) Figure 42. Germany Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 43. France Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 44. UK Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 45. Italy Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 46. Russia Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 47. Middle East & Africa Targeted Protein Degradation Therapy Market Size Market Share by Region (2021-2026) Figure 48. Middle East & Africa Targeted Protein Degradation Therapy Market Size Market Share by Type (2021-2026) Figure 49. Middle East & Africa Targeted Protein Degradation Therapy Market Size Market Share by Application (2021-2026) Figure 50. Egypt Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 51. South Africa Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 52. Israel Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 53. Turkey Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 54. GCC Countries Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 55. Americas Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 56. APAC Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 57. Europe Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 58. Middle East & Africa Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 59. United States Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 60. Canada Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 61. Mexico Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 62. Brazil Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 63. China Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 64. Japan Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 65. Korea Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 66. Southeast Asia Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 67. India Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 68. Australia Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 69. Germany Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 70. France Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 71. UK Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 72. Italy Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 73. Russia Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 74. Egypt Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 75. South Africa Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 76. Israel Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 77. Turkey Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 78. Global Targeted Protein Degradation Therapy Market Size Market Share Forecast by Type (2027-2032) Figure 79. Global Targeted Protein Degradation Therapy Market Size Market Share Forecast by Application (2027-2032) Figure 80. GCC Countries Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions)
SummaryThe global Targeted Protein Degradation Therapy market size is predicted to grow from US$ 130 million in 2025 to US$ 428 million in 2032; it is expected to grow at a CAGR of 18.9% from 2026 to 2032.Targeted Protein Degradation (TPD) therapy is an innovative approach in drug development that harnesses the cell’s natural protein disposal system to eliminate disease-causing proteins rather than simply inhibiting their activity. This strategy uses small molecules, such as PROTACs (Proteolysis Targeting Chimeras), to tag specific proteins for degradation by the ubiquitin-proteasome system. TPD offers a novel way to address previously “undruggable” targets and can provide more sustained therapeutic effects with potentially lower doses. It is being actively explored for the treatment of cancer, neurodegenerative disorders, and autoimmune diseases, with several candidates in clinical trials. Global key Targeted Protein Degradation Therapy players cover Arvinas, Kymera Therapeutics, Dialectic Therapeutics, Bristol-Myers Squibb, Nurix, etc. Report Scope LPI (LP Information)' newest research report, the “Targeted Protein Degradation Therapy Industry Forecast” looks at past sales and reviews total world Targeted Protein Degradation Therapy sales in 2025, providing a comprehensive analysis by region and market sector of projected Targeted Protein Degradation Therapy sales for 2026 through 2032. With Targeted Protein Degradation Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Protein Degradation Therapy industry. This Insight Report provides a comprehensive analysis of the global Targeted Protein Degradation Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Targeted Protein Degradation Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted Protein Degradation Therapy market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Protein Degradation Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Protein Degradation Therapy. This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Protein Degradation Therapy market by product type, application, key players and key regions and countries. Market Segmentation Segmentation by Type: Molecular Glues (CELMoDTM Agents) Ligand-directed Degraders (LDDs) Antibody Drug Conjugate (ADC) Degraders Segmentation by Application: Prostate Cancer Breast Cancer Lymphoma Others This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. Arvinas Kymera Therapeutics Dialectic Therapeutics Bristol-Myers Squibb Nurix Cullgen C4 Therapeutics Foghorn Novartis Pfizer MSD Origami Therapeutics NEOsphere Biotechnologies Dunad Therapeutics Entact Bio Proxygen Monte Rosa Therapeutics Treeline Biosciences Ubiquigent Kangpu Biopharmaceuticals Ranok Therapeutics Accutar Biotech BeiGene Hinova Pharma Haisco Pharmaceutical CTTQ Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Targeted Protein Degradation Therapy Market Size (2021-2032) 2.1.2 Targeted Protein Degradation Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032) 2.1.3 World Current & Future Analysis for Targeted Protein Degradation Therapy by Country/Region (2021, 2025 & 2032) 2.2 Targeted Protein Degradation Therapy Segment by Type 2.2.1 Molecular Glues (CELMoDTM Agents) 2.2.2 Ligand-directed Degraders (LDDs) 2.2.3 Antibody Drug Conjugate (ADC) Degraders 2.2.4 Targeted Protein Degradation Therapy Market Size by Type 2.2.4.1 Targeted Protein Degradation Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032) 2.2.4.2 Global Targeted Protein Degradation Therapy Market Size Market Share by Type (2021-2026) 2.3 Targeted Protein Degradation Therapy Segment by Application 2.3.1 Prostate Cancer 2.3.2 Breast Cancer 2.3.3 Lymphoma 2.3.4 Others 2.3.5 Targeted Protein Degradation Therapy Market Size by Application 2.3.5.1 Targeted Protein Degradation Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032) 2.3.5.2 Global Targeted Protein Degradation Therapy Market Size Market Share by Application (2021-2026) 3 Targeted Protein Degradation Therapy Market Size by Player 3.1 Targeted Protein Degradation Therapy Market Size Market Share by Player 3.1.1 Global Targeted Protein Degradation Therapy Revenue by Player (2021-2026) 3.1.2 Global Targeted Protein Degradation Therapy Revenue Market Share by Player (2021-2026) 3.2 Global Targeted Protein Degradation Therapy Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Targeted Protein Degradation Therapy by Region 4.1 Targeted Protein Degradation Therapy Market Size by Region (2021-2026) 4.2 Global Targeted Protein Degradation Therapy Annual Revenue by Country/Region (2021-2026) 4.3 Americas Targeted Protein Degradation Therapy Market Size Growth (2021-2026) 4.4 APAC Targeted Protein Degradation Therapy Market Size Growth (2021-2026) 4.5 Europe Targeted Protein Degradation Therapy Market Size Growth (2021-2026) 4.6 Middle East & Africa Targeted Protein Degradation Therapy Market Size Growth (2021-2026) 5 Americas 5.1 Americas Targeted Protein Degradation Therapy Market Size by Country (2021-2026) 5.2 Americas Targeted Protein Degradation Therapy Market Size by Type (2021-2026) 5.3 Americas Targeted Protein Degradation Therapy Market Size by Application (2021-2026) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Targeted Protein Degradation Therapy Market Size by Region (2021-2026) 6.2 APAC Targeted Protein Degradation Therapy Market Size by Type (2021-2026) 6.3 APAC Targeted Protein Degradation Therapy Market Size by Application (2021-2026) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Targeted Protein Degradation Therapy Market Size by Country (2021-2026) 7.2 Europe Targeted Protein Degradation Therapy Market Size by Type (2021-2026) 7.3 Europe Targeted Protein Degradation Therapy Market Size by Application (2021-2026) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Targeted Protein Degradation Therapy by Region (2021-2026) 8.2 Middle East & Africa Targeted Protein Degradation Therapy Market Size by Type (2021-2026) 8.3 Middle East & Africa Targeted Protein Degradation Therapy Market Size by Application (2021-2026) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Targeted Protein Degradation Therapy Market Forecast 10.1 Global Targeted Protein Degradation Therapy Forecast by Region (2027-2032) 10.1.1 Global Targeted Protein Degradation Therapy Forecast by Region (2027-2032) 10.1.2 Americas Targeted Protein Degradation Therapy Forecast 10.1.3 APAC Targeted Protein Degradation Therapy Forecast 10.1.4 Europe Targeted Protein Degradation Therapy Forecast 10.1.5 Middle East & Africa Targeted Protein Degradation Therapy Forecast 10.2 Americas Targeted Protein Degradation Therapy Forecast by Country (2027-2032) 10.2.1 United States Market Targeted Protein Degradation Therapy Forecast 10.2.2 Canada Market Targeted Protein Degradation Therapy Forecast 10.2.3 Mexico Market Targeted Protein Degradation Therapy Forecast 10.2.4 Brazil Market Targeted Protein Degradation Therapy Forecast 10.3 APAC Targeted Protein Degradation Therapy Forecast by Region (2027-2032) 10.3.1 China Targeted Protein Degradation Therapy Market Forecast 10.3.2 Japan Market Targeted Protein Degradation Therapy Forecast 10.3.3 Korea Market Targeted Protein Degradation Therapy Forecast 10.3.4 Southeast Asia Market Targeted Protein Degradation Therapy Forecast 10.3.5 India Market Targeted Protein Degradation Therapy Forecast 10.3.6 Australia Market Targeted Protein Degradation Therapy Forecast 10.4 Europe Targeted Protein Degradation Therapy Forecast by Country (2027-2032) 10.4.1 Germany Market Targeted Protein Degradation Therapy Forecast 10.4.2 France Market Targeted Protein Degradation Therapy Forecast 10.4.3 UK Market Targeted Protein Degradation Therapy Forecast 10.4.4 Italy Market Targeted Protein Degradation Therapy Forecast 10.4.5 Russia Market Targeted Protein Degradation Therapy Forecast 10.5 Middle East & Africa Targeted Protein Degradation Therapy Forecast by Region (2027-2032) 10.5.1 Egypt Market Targeted Protein Degradation Therapy Forecast 10.5.2 South Africa Market Targeted Protein Degradation Therapy Forecast 10.5.3 Israel Market Targeted Protein Degradation Therapy Forecast 10.5.4 Turkey Market Targeted Protein Degradation Therapy Forecast 10.6 Global Targeted Protein Degradation Therapy Forecast by Type (2027-2032) 10.7 Global Targeted Protein Degradation Therapy Forecast by Application (2027-2032) 10.7.1 GCC Countries Market Targeted Protein Degradation Therapy Forecast 11 Key Players Analysis 11.1 Arvinas 11.1.1 Arvinas Company Information 11.1.2 Arvinas Targeted Protein Degradation Therapy Product Offered 11.1.3 Arvinas Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2021-2026) 11.1.4 Arvinas Main Business Overview 11.1.5 Arvinas Latest Developments 11.2 Kymera Therapeutics 11.2.1 Kymera Therapeutics Company Information 11.2.2 Kymera Therapeutics Targeted Protein Degradation Therapy Product Offered 11.2.3 Kymera Therapeutics Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2021-2026) 11.2.4 Kymera Therapeutics Main Business Overview 11.2.5 Kymera Therapeutics Latest Developments 11.3 Dialectic Therapeutics 11.3.1 Dialectic Therapeutics Company Information 11.3.2 Dialectic Therapeutics Targeted Protein Degradation Therapy Product Offered 11.3.3 Dialectic Therapeutics Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2021-2026) 11.3.4 Dialectic Therapeutics Main Business Overview 11.3.5 Dialectic Therapeutics Latest Developments 11.4 Bristol-Myers Squibb 11.4.1 Bristol-Myers Squibb Company Information 11.4.2 Bristol-Myers Squibb Targeted Protein Degradation Therapy Product Offered 11.4.3 Bristol-Myers Squibb Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2021-2026) 11.4.4 Bristol-Myers Squibb Main Business Overview 11.4.5 Bristol-Myers Squibb Latest Developments 11.5 Nurix 11.5.1 Nurix Company Information 11.5.2 Nurix Targeted Protein Degradation Therapy Product Offered 11.5.3 Nurix Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2021-2026) 11.5.4 Nurix Main Business Overview 11.5.5 Nurix Latest Developments 11.6 Cullgen 11.6.1 Cullgen Company Information 11.6.2 Cullgen Targeted Protein Degradation Therapy Product Offered 11.6.3 Cullgen Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2021-2026) 11.6.4 Cullgen Main Business Overview 11.6.5 Cullgen Latest Developments 11.7 C4 Therapeutics 11.7.1 C4 Therapeutics Company Information 11.7.2 C4 Therapeutics Targeted Protein Degradation Therapy Product Offered 11.7.3 C4 Therapeutics Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2021-2026) 11.7.4 C4 Therapeutics Main Business Overview 11.7.5 C4 Therapeutics Latest Developments 11.8 Foghorn 11.8.1 Foghorn Company Information 11.8.2 Foghorn Targeted Protein Degradation Therapy Product Offered 11.8.3 Foghorn Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2021-2026) 11.8.4 Foghorn Main Business Overview 11.8.5 Foghorn Latest Developments 11.9 Novartis 11.9.1 Novartis Company Information 11.9.2 Novartis Targeted Protein Degradation Therapy Product Offered 11.9.3 Novartis Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2021-2026) 11.9.4 Novartis Main Business Overview 11.9.5 Novartis Latest Developments 11.10 Pfizer 11.10.1 Pfizer Company Information 11.10.2 Pfizer Targeted Protein Degradation Therapy Product Offered 11.10.3 Pfizer Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2021-2026) 11.10.4 Pfizer Main Business Overview 11.10.5 Pfizer Latest Developments 11.11 MSD 11.11.1 MSD Company Information 11.11.2 MSD Targeted Protein Degradation Therapy Product Offered 11.11.3 MSD Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2021-2026) 11.11.4 MSD Main Business Overview 11.11.5 MSD Latest Developments 11.12 Origami Therapeutics 11.12.1 Origami Therapeutics Company Information 11.12.2 Origami Therapeutics Targeted Protein Degradation Therapy Product Offered 11.12.3 Origami Therapeutics Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2021-2026) 11.12.4 Origami Therapeutics Main Business Overview 11.12.5 Origami Therapeutics Latest Developments 11.13 NEOsphere Biotechnologies 11.13.1 NEOsphere Biotechnologies Company Information 11.13.2 NEOsphere Biotechnologies Targeted Protein Degradation Therapy Product Offered 11.13.3 NEOsphere Biotechnologies Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2021-2026) 11.13.4 NEOsphere Biotechnologies Main Business Overview 11.13.5 NEOsphere Biotechnologies Latest Developments 11.14 Dunad Therapeutics 11.14.1 Dunad Therapeutics Company Information 11.14.2 Dunad Therapeutics Targeted Protein Degradation Therapy Product Offered 11.14.3 Dunad Therapeutics Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2021-2026) 11.14.4 Dunad Therapeutics Main Business Overview 11.14.5 Dunad Therapeutics Latest Developments 11.15 Entact Bio 11.15.1 Entact Bio Company Information 11.15.2 Entact Bio Targeted Protein Degradation Therapy Product Offered 11.15.3 Entact Bio Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2021-2026) 11.15.4 Entact Bio Main Business Overview 11.15.5 Entact Bio Latest Developments 11.16 Proxygen 11.16.1 Proxygen Company Information 11.16.2 Proxygen Targeted Protein Degradation Therapy Product Offered 11.16.3 Proxygen Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2021-2026) 11.16.4 Proxygen Main Business Overview 11.16.5 Proxygen Latest Developments 11.17 Monte Rosa Therapeutics 11.17.1 Monte Rosa Therapeutics Company Information 11.17.2 Monte Rosa Therapeutics Targeted Protein Degradation Therapy Product Offered 11.17.3 Monte Rosa Therapeutics Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2021-2026) 11.17.4 Monte Rosa Therapeutics Main Business Overview 11.17.5 Monte Rosa Therapeutics Latest Developments 11.18 Treeline Biosciences 11.18.1 Treeline Biosciences Company Information 11.18.2 Treeline Biosciences Targeted Protein Degradation Therapy Product Offered 11.18.3 Treeline Biosciences Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2021-2026) 11.18.4 Treeline Biosciences Main Business Overview 11.18.5 Treeline Biosciences Latest Developments 11.19 Ubiquigent 11.19.1 Ubiquigent Company Information 11.19.2 Ubiquigent Targeted Protein Degradation Therapy Product Offered 11.19.3 Ubiquigent Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2021-2026) 11.19.4 Ubiquigent Main Business Overview 11.19.5 Ubiquigent Latest Developments 11.20 Kangpu Biopharmaceuticals 11.20.1 Kangpu Biopharmaceuticals Company Information 11.20.2 Kangpu Biopharmaceuticals Targeted Protein Degradation Therapy Product Offered 11.20.3 Kangpu Biopharmaceuticals Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2021-2026) 11.20.4 Kangpu Biopharmaceuticals Main Business Overview 11.20.5 Kangpu Biopharmaceuticals Latest Developments 11.21 Ranok Therapeutics 11.21.1 Ranok Therapeutics Company Information 11.21.2 Ranok Therapeutics Targeted Protein Degradation Therapy Product Offered 11.21.3 Ranok Therapeutics Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2021-2026) 11.21.4 Ranok Therapeutics Main Business Overview 11.21.5 Ranok Therapeutics Latest Developments 11.22 Accutar Biotech 11.22.1 Accutar Biotech Company Information 11.22.2 Accutar Biotech Targeted Protein Degradation Therapy Product Offered 11.22.3 Accutar Biotech Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2021-2026) 11.22.4 Accutar Biotech Main Business Overview 11.22.5 Accutar Biotech Latest Developments 11.23 BeiGene 11.23.1 BeiGene Company Information 11.23.2 BeiGene Targeted Protein Degradation Therapy Product Offered 11.23.3 BeiGene Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2021-2026) 11.23.4 BeiGene Main Business Overview 11.23.5 BeiGene Latest Developments 11.24 Hinova Pharma 11.24.1 Hinova Pharma Company Information 11.24.2 Hinova Pharma Targeted Protein Degradation Therapy Product Offered 11.24.3 Hinova Pharma Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2021-2026) 11.24.4 Hinova Pharma Main Business Overview 11.24.5 Hinova Pharma Latest Developments 11.25 Haisco Pharmaceutical 11.25.1 Haisco Pharmaceutical Company Information 11.25.2 Haisco Pharmaceutical Targeted Protein Degradation Therapy Product Offered 11.25.3 Haisco Pharmaceutical Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2021-2026) 11.25.4 Haisco Pharmaceutical Main Business Overview 11.25.5 Haisco Pharmaceutical Latest Developments 11.26 CTTQ 11.26.1 CTTQ Company Information 11.26.2 CTTQ Targeted Protein Degradation Therapy Product Offered 11.26.3 CTTQ Targeted Protein Degradation Therapy Revenue, Gross Margin and Market Share (2021-2026) 11.26.4 CTTQ Main Business Overview 11.26.5 CTTQ Latest Developments 12 Research Findings and Conclusion List of Tables/GraphsList of TablesTable 1. Targeted Protein Degradation Therapy Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions) Table 2. Targeted Protein Degradation Therapy Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions) Table 3. Major Players of Molecular Glues (CELMoDTM Agents) Table 4. Major Players of Ligand-directed Degraders (LDDs) Table 5. Major Players of Antibody Drug Conjugate (ADC) Degraders Table 6. Targeted Protein Degradation Therapy Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions) Table 7. Global Targeted Protein Degradation Therapy Market Size by Type (2021-2026) & ($ millions) Table 8. Global Targeted Protein Degradation Therapy Market Size Market Share by Type (2021-2026) Table 9. Targeted Protein Degradation Therapy Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions) Table 10. Global Targeted Protein Degradation Therapy Market Size by Application (2021-2026) & ($ millions) Table 11. Global Targeted Protein Degradation Therapy Market Size Market Share by Application (2021-2026) Table 12. Global Targeted Protein Degradation Therapy Revenue by Player (2021-2026) & ($ millions) Table 13. Global Targeted Protein Degradation Therapy Revenue Market Share by Player (2021-2026) Table 14. Targeted Protein Degradation Therapy Key Players Head office and Products Offered Table 15. Targeted Protein Degradation Therapy Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) Table 16. New Products and Potential Entrants Table 17. Mergers & Acquisitions, Expansion Table 18. Global Targeted Protein Degradation Therapy Market Size by Region (2021-2026) & ($ millions) Table 19. Global Targeted Protein Degradation Therapy Market Size Market Share by Region (2021-2026) Table 20. Global Targeted Protein Degradation Therapy Revenue by Country/Region (2021-2026) & ($ millions) Table 21. Global Targeted Protein Degradation Therapy Revenue Market Share by Country/Region (2021-2026) Table 22. Americas Targeted Protein Degradation Therapy Market Size by Country (2021-2026) & ($ millions) Table 23. Americas Targeted Protein Degradation Therapy Market Size Market Share by Country (2021-2026) Table 24. Americas Targeted Protein Degradation Therapy Market Size by Type (2021-2026) & ($ millions) Table 25. Americas Targeted Protein Degradation Therapy Market Size Market Share by Type (2021-2026) Table 26. Americas Targeted Protein Degradation Therapy Market Size by Application (2021-2026) & ($ millions) Table 27. Americas Targeted Protein Degradation Therapy Market Size Market Share by Application (2021-2026) Table 28. APAC Targeted Protein Degradation Therapy Market Size by Region (2021-2026) & ($ millions) Table 29. APAC Targeted Protein Degradation Therapy Market Size Market Share by Region (2021-2026) Table 30. APAC Targeted Protein Degradation Therapy Market Size by Type (2021-2026) & ($ millions) Table 31. APAC Targeted Protein Degradation Therapy Market Size by Application (2021-2026) & ($ millions) Table 32. Europe Targeted Protein Degradation Therapy Market Size by Country (2021-2026) & ($ millions) Table 33. Europe Targeted Protein Degradation Therapy Market Size Market Share by Country (2021-2026) Table 34. Europe Targeted Protein Degradation Therapy Market Size by Type (2021-2026) & ($ millions) Table 35. Europe Targeted Protein Degradation Therapy Market Size by Application (2021-2026) & ($ millions) Table 36. Middle East & Africa Targeted Protein Degradation Therapy Market Size by Region (2021-2026) & ($ millions) Table 37. Middle East & Africa Targeted Protein Degradation Therapy Market Size by Type (2021-2026) & ($ millions) Table 38. Middle East & Africa Targeted Protein Degradation Therapy Market Size by Application (2021-2026) & ($ millions) Table 39. Key Market Drivers & Growth Opportunities of Targeted Protein Degradation Therapy Table 40. Key Market Challenges & Risks of Targeted Protein Degradation Therapy Table 41. Key Industry Trends of Targeted Protein Degradation Therapy Table 42. Global Targeted Protein Degradation Therapy Market Size Forecast by Region (2027-2032) & ($ millions) Table 43. Global Targeted Protein Degradation Therapy Market Size Market Share Forecast by Region (2027-2032) Table 44. Global Targeted Protein Degradation Therapy Market Size Forecast by Type (2027-2032) & ($ millions) Table 45. Global Targeted Protein Degradation Therapy Market Size Forecast by Application (2027-2032) & ($ millions) Table 46. Arvinas Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 47. Arvinas Targeted Protein Degradation Therapy Product Offered Table 48. Arvinas Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 49. Arvinas Main Business Table 50. Arvinas Latest Developments Table 51. Kymera Therapeutics Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 52. Kymera Therapeutics Targeted Protein Degradation Therapy Product Offered Table 53. Kymera Therapeutics Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 54. Kymera Therapeutics Main Business Table 55. Kymera Therapeutics Latest Developments Table 56. Dialectic Therapeutics Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 57. Dialectic Therapeutics Targeted Protein Degradation Therapy Product Offered Table 58. Dialectic Therapeutics Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 59. Dialectic Therapeutics Main Business Table 60. Dialectic Therapeutics Latest Developments Table 61. Bristol-Myers Squibb Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 62. Bristol-Myers Squibb Targeted Protein Degradation Therapy Product Offered Table 63. Bristol-Myers Squibb Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 64. Bristol-Myers Squibb Main Business Table 65. Bristol-Myers Squibb Latest Developments Table 66. Nurix Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 67. Nurix Targeted Protein Degradation Therapy Product Offered Table 68. Nurix Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 69. Nurix Main Business Table 70. Nurix Latest Developments Table 71. Cullgen Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 72. Cullgen Targeted Protein Degradation Therapy Product Offered Table 73. Cullgen Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 74. Cullgen Main Business Table 75. Cullgen Latest Developments Table 76. C4 Therapeutics Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 77. C4 Therapeutics Targeted Protein Degradation Therapy Product Offered Table 78. C4 Therapeutics Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 79. C4 Therapeutics Main Business Table 80. C4 Therapeutics Latest Developments Table 81. Foghorn Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 82. Foghorn Targeted Protein Degradation Therapy Product Offered Table 83. Foghorn Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 84. Foghorn Main Business Table 85. Foghorn Latest Developments Table 86. Novartis Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 87. Novartis Targeted Protein Degradation Therapy Product Offered Table 88. Novartis Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 89. Novartis Main Business Table 90. Novartis Latest Developments Table 91. Pfizer Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 92. Pfizer Targeted Protein Degradation Therapy Product Offered Table 93. Pfizer Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 94. Pfizer Main Business Table 95. Pfizer Latest Developments Table 96. MSD Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 97. MSD Targeted Protein Degradation Therapy Product Offered Table 98. MSD Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 99. MSD Main Business Table 100. MSD Latest Developments Table 101. Origami Therapeutics Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 102. Origami Therapeutics Targeted Protein Degradation Therapy Product Offered Table 103. Origami Therapeutics Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 104. Origami Therapeutics Main Business Table 105. Origami Therapeutics Latest Developments Table 106. NEOsphere Biotechnologies Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 107. NEOsphere Biotechnologies Targeted Protein Degradation Therapy Product Offered Table 108. NEOsphere Biotechnologies Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 109. NEOsphere Biotechnologies Main Business Table 110. NEOsphere Biotechnologies Latest Developments Table 111. Dunad Therapeutics Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 112. Dunad Therapeutics Targeted Protein Degradation Therapy Product Offered Table 113. Dunad Therapeutics Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 114. Dunad Therapeutics Main Business Table 115. Dunad Therapeutics Latest Developments Table 116. Entact Bio Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 117. Entact Bio Targeted Protein Degradation Therapy Product Offered Table 118. Entact Bio Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 119. Entact Bio Main Business Table 120. Entact Bio Latest Developments Table 121. Proxygen Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 122. Proxygen Targeted Protein Degradation Therapy Product Offered Table 123. Proxygen Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 124. Proxygen Main Business Table 125. Proxygen Latest Developments Table 126. Monte Rosa Therapeutics Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 127. Monte Rosa Therapeutics Targeted Protein Degradation Therapy Product Offered Table 128. Monte Rosa Therapeutics Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 129. Monte Rosa Therapeutics Main Business Table 130. Monte Rosa Therapeutics Latest Developments Table 131. Treeline Biosciences Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 132. Treeline Biosciences Targeted Protein Degradation Therapy Product Offered Table 133. Treeline Biosciences Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 134. Treeline Biosciences Main Business Table 135. Treeline Biosciences Latest Developments Table 136. Ubiquigent Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 137. Ubiquigent Targeted Protein Degradation Therapy Product Offered Table 138. Ubiquigent Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 139. Ubiquigent Main Business Table 140. Ubiquigent Latest Developments Table 141. Kangpu Biopharmaceuticals Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 142. Kangpu Biopharmaceuticals Targeted Protein Degradation Therapy Product Offered Table 143. Kangpu Biopharmaceuticals Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 144. Kangpu Biopharmaceuticals Main Business Table 145. Kangpu Biopharmaceuticals Latest Developments Table 146. Ranok Therapeutics Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 147. Ranok Therapeutics Targeted Protein Degradation Therapy Product Offered Table 148. Ranok Therapeutics Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 149. Ranok Therapeutics Main Business Table 150. Ranok Therapeutics Latest Developments Table 151. Accutar Biotech Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 152. Accutar Biotech Targeted Protein Degradation Therapy Product Offered Table 153. Accutar Biotech Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 154. Accutar Biotech Main Business Table 155. Accutar Biotech Latest Developments Table 156. BeiGene Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 157. BeiGene Targeted Protein Degradation Therapy Product Offered Table 158. BeiGene Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 159. BeiGene Main Business Table 160. BeiGene Latest Developments Table 161. Hinova Pharma Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 162. Hinova Pharma Targeted Protein Degradation Therapy Product Offered Table 163. Hinova Pharma Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 164. Hinova Pharma Main Business Table 165. Hinova Pharma Latest Developments Table 166. Haisco Pharmaceutical Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 167. Haisco Pharmaceutical Targeted Protein Degradation Therapy Product Offered Table 168. Haisco Pharmaceutical Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 169. Haisco Pharmaceutical Main Business Table 170. Haisco Pharmaceutical Latest Developments Table 171. CTTQ Details, Company Type, Targeted Protein Degradation Therapy Area Served and Its Competitors Table 172. CTTQ Targeted Protein Degradation Therapy Product Offered Table 173. CTTQ Targeted Protein Degradation Therapy Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 174. CTTQ Main Business Table 175. CTTQ Latest Developments List of Figures Figure 1. Targeted Protein Degradation Therapy Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Targeted Protein Degradation Therapy Market Size Growth Rate (2021-2032) ($ millions) Figure 6. Targeted Protein Degradation Therapy Sales by Geographic Region (2021, 2025 & 2032) & ($ millions) Figure 7. Targeted Protein Degradation Therapy Sales Market Share by Country/Region (2025) Figure 8. Targeted Protein Degradation Therapy Sales Market Share by Country/Region (2021, 2025 & 2032) Figure 9. Global Targeted Protein Degradation Therapy Market Size Market Share by Type in 2025 Figure 10. Targeted Protein Degradation Therapy in Prostate Cancer Figure 11. Global Targeted Protein Degradation Therapy Market: Prostate Cancer (2021-2026) & ($ millions) Figure 12. Targeted Protein Degradation Therapy in Breast Cancer Figure 13. Global Targeted Protein Degradation Therapy Market: Breast Cancer (2021-2026) & ($ millions) Figure 14. Targeted Protein Degradation Therapy in Lymphoma Figure 15. Global Targeted Protein Degradation Therapy Market: Lymphoma (2021-2026) & ($ millions) Figure 16. Targeted Protein Degradation Therapy in Others Figure 17. Global Targeted Protein Degradation Therapy Market: Others (2021-2026) & ($ millions) Figure 18. Global Targeted Protein Degradation Therapy Market Size Market Share by Application in 2025 Figure 19. Global Targeted Protein Degradation Therapy Revenue Market Share by Player in 2025 Figure 20. Global Targeted Protein Degradation Therapy Market Size Market Share by Region (2021-2026) Figure 21. Americas Targeted Protein Degradation Therapy Market Size 2021-2026 ($ millions) Figure 22. APAC Targeted Protein Degradation Therapy Market Size 2021-2026 ($ millions) Figure 23. Europe Targeted Protein Degradation Therapy Market Size 2021-2026 ($ millions) Figure 24. Middle East & Africa Targeted Protein Degradation Therapy Market Size 2021-2026 ($ millions) Figure 25. Americas Targeted Protein Degradation Therapy Value Market Share by Country in 2025 Figure 26. United States Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 27. Canada Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 28. Mexico Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 29. Brazil Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 30. APAC Targeted Protein Degradation Therapy Market Size Market Share by Region in 2025 Figure 31. APAC Targeted Protein Degradation Therapy Market Size Market Share by Type (2021-2026) Figure 32. APAC Targeted Protein Degradation Therapy Market Size Market Share by Application (2021-2026) Figure 33. China Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 34. Japan Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 35. South Korea Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 36. Southeast Asia Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 37. India Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 38. Australia Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 39. Europe Targeted Protein Degradation Therapy Market Size Market Share by Country in 2025 Figure 40. Europe Targeted Protein Degradation Therapy Market Size Market Share by Type (2021-2026) Figure 41. Europe Targeted Protein Degradation Therapy Market Size Market Share by Application (2021-2026) Figure 42. Germany Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 43. France Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 44. UK Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 45. Italy Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 46. Russia Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 47. Middle East & Africa Targeted Protein Degradation Therapy Market Size Market Share by Region (2021-2026) Figure 48. Middle East & Africa Targeted Protein Degradation Therapy Market Size Market Share by Type (2021-2026) Figure 49. Middle East & Africa Targeted Protein Degradation Therapy Market Size Market Share by Application (2021-2026) Figure 50. Egypt Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 51. South Africa Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 52. Israel Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 53. Turkey Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 54. GCC Countries Targeted Protein Degradation Therapy Market Size Growth 2021-2026 ($ millions) Figure 55. Americas Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 56. APAC Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 57. Europe Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 58. Middle East & Africa Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 59. United States Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 60. Canada Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 61. Mexico Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 62. Brazil Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 63. China Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 64. Japan Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 65. Korea Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 66. Southeast Asia Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 67. India Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 68. Australia Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 69. Germany Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 70. France Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 71. UK Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 72. Italy Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 73. Russia Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 74. Egypt Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 75. South Africa Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 76. Israel Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 77. Turkey Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions) Figure 78. Global Targeted Protein Degradation Therapy Market Size Market Share Forecast by Type (2027-2032) Figure 79. Global Targeted Protein Degradation Therapy Market Size Market Share Forecast by Application (2027-2032) Figure 80. GCC Countries Targeted Protein Degradation Therapy Market Size 2027-2032 ($ millions)
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポートLP Information社の 医療分野 での最新刊レポート本レポートと同じKEY WORD(protein)の最新刊レポート
よくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|